1. Antonovych T.T., Sabnis S.G., Austin H.A., Palestine A.G., Balow J.E., Nussenblatt R.B., Helfrich G.B., Foegh M.L., Alijani M.R.: Cyclosporin A-induced arteriolopathy.Transplant. Proc. 20, 951–958 (1988).
2. Bach J.F., Chatenoud L.: Immunologic monitoring of Orthoclone OKT 3-treated patients—the problem of antimonoclonal immune response.Transplant. Proc. 19, 17–20 (1987).
3. Baumann G.: Molecular mechanisms of immunosuppressive agents.Transplant. Proc. 24, 4–7 (1992).
4. Belnap L.G.P., Hammond E.H., Yowell R., Richards K.F., Rees W.V., Stevens L.E.: Baseline biopsies define cyclosporine nephrotoxicity.Transplant. Proc. 21, 1485–1486 (1989).
5. Bechorner W.E., Namnoun J.D., Hess A.D., Shinn C.A., Santos G.W.: Cyclosporin A and the thymus.Amer. J. Pathol. 126, 487–496 (1987).